Tango Therapeutics (TNGX) Short Interest
Nasdaq • TNGX • US87583X1090
As of Oct 27, 2026, ORTEX estimated 38.6% of free float sold short, 10.1 days to cover, cost to borrow 0.55%. Sign up for live short interest data.
Nasdaq • TNGX • US87583X1090
As of Oct 27, 2026, ORTEX estimated 38.6% of free float sold short, 10.1 days to cover, cost to borrow 0.55%. Sign up for live short interest data.
This page tracks how heavily Tango Therapeutics (Nasdaq:TNGX) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Tango Therapeutics (Nasdaq: TNGX) has a market capitalization of $4.36B. Last close $25.73 (as of 2026-11-12); 52-week range $7.49 to $34.39. ORTEX data as of 2026-10-27: short interest was 38.57% of free float, 10.1 days to cover and the average cost to borrow was 0.55%. Sign up for live short interest data.